litlas
Log inCreate account

Zoe Arvanitakis

Active 2002–2025

72
Papers
18,539
Citations
47
h-index
64
i10-index

Citations

Citations per year for Zoe Arvanitakis2003: 1 citations2004: 8 citations2005: 19 citations2006: 34 citations2007: 78 citations2008: 104 citations2009: 150 citations2010: 156 citations2011: 192 citations2012: 213 citations2013: 232 citations2014: 235 citations2015: 196 citations2016: 244 citations2017: 249 citations2018: 295 citations2019: 844 citations2020: 896 citations2021: 897 citations2022: 882 citations2023: 632 citations2024: 1,018 citations2025: 545 citations2026: 20 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,161 citing papers, 31.6% of this breakdownChina: 960 citing papers, 9.6% of this breakdownUnited Kingdom: 744 citing papers, 7.4% of this breakdownCanada: 483 citing papers, 4.8% of this breakdownGermany: 347 citing papers, 3.5% of this breakdownAustralia: 338 citing papers, 3.4% of this breakdownItaly: 318 citing papers, 3.2% of this breakdownSweden: 317 citing papers, 3.2% of this breakdownNetherlands: 272 citing papers, 2.7% of this breakdownSpain: 250 citing papers, 2.5% of this breakdownJapan: 209 citing papers, 2.1% of this breakdownFrance: 207 citing papers, 2.1% of this breakdown
0%31.6%Other 23.9%

Institutions

Fields

  • Medicine69%
  • Neuroscience13.3%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Psychology1%
  • Computer Science1%
  • Health Professions1%
  • Other3.2%

Topics

  • Alzheimer's disease research and treatments14.3%
  • Dementia and Cognitive Impairment Research11.8%
  • Neurological Disease Mechanisms and Treatments3.8%
  • Neuroinflammation and Neurodegeneration Mechanisms3.2%
  • Diet and metabolism studies1.8%
  • Parkinson's Disease Mechanisms and Treatments1.7%
  • Other63.4%

Coauthors

All papers

Open in search
  1. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

    Authors: Steven E. Arnold, Zoe Arvanitakis, Shannon L. Macauley, Aaron Koenig, Hoau-Yan Wang, Rexford S. Ahima, Suzanne Craft, Sam Gandy, Christoph Buettner, Luke E. Stoeckel, David M. Holtzman, David M. Nathan - Nature Reviews Neurology 2018 cited by 1,521

  2. Diagnosis and Management of Dementia: Review

    Authors: Zoe Arvanitakis, Raj C. Shah, David A. Bennett - JAMA 2019 cited by 1,402

  3. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

    Authors: Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Liying Han, Kalindi Bakshi, Andres Stucky, Robert L. Fuino, Krista R. Kawaguchi, Andrew Samoyedny, Robert S. Wilson, Zoe Arvanitakis, Julie A. Schneider, Bryan A. Wolf, David A. Bennett, John Q. Trojanowski, Steven E. Arnold - Journal of Clinical Investigation 2012 cited by 1,836

  4. Mixed brain pathologies account for most dementia cases in community-dwelling older persons

    Authors: Julie A. Schneider, Zoe Arvanitakis, Woojeong Bang, David A. Bennett - Neurology 2007 cited by 1,993

  5. Neuropathology of older persons without cognitive impairment from two community-based studies

    Authors: David A. Bennett, Julie A. Schneider, Zoe Arvanitakis, Jeremiah F. Kelly, Neelum T. Aggarwal, Raj C. Shah, R. J. Wilson - Neurology 2006 cited by 1,356

  6. Vascular dysfunction—The disregarded partner of Alzheimer's disease

    Authors: Melanie D. Sweeney, Axel Montagne, Abhay P. Sagare, Daniel A. Nation, Lon S. Schneider, Helena C. Chui, Michael G. Harrington, Judy Pa, Meng Law, Danny J.J. Wang, Russell E. Jacobs, Fergus Doubal, Joel Ramirez, Sandra E. Black, Maiken Nedergaard, Helene Benveniste, Martin Dichgans, Costantino Iadecola, Seth Love, Philip M. Bath, Hugh S. Markus, Rustam Al‐Shahi Salman, Stuart M. Allan, Terence J. Quinn, Rajesh N. Kalaria, David J. Werring, Roxana O. Carare, Rhian M. Touyz, Steven Williams, Michael A. Moskowitz, Zvonimir S. Katušić, Sarah E. Lutz, Orly Lazarov, Richard D. Minshall, Jalees Rehman, Thomas P. Davis, Cheryl L. Wellington, Hector M. González, Chun Yuan, Samuel N. Lockhart, Timothy M. Hughes, Christopher Chen, Perminder S. Sachdev, John T. O’Brien, Ingmar Skoog, Leonardo Pantoni, Deborah Gustafson, Geert Jan Biessels, Anders Wallin, Eric E. Smith, Vincent Mok, Adrian Wong, Peter Passmore, Frederick Barkof, Majon Muller, Monique M.B. Breteler, Gustavo C. Román, Édith Hamel, Sudha Seshadri, Rebecca F. Gottesman, Mark A. van Buchem, Zoe Arvanitakis, Julie A. Schneider, Lester R. Drewes, Vladimir Hachinski, Caleb E. Finch, Arthur W. Toga, Joanna M. Wardlaw, Berislav V. Zloković - Alzheimer s & Dementia 2019 cited by 723

  7. The neuropathology of probable Alzheimer disease and mild cognitive impairment

    Authors: Julie A. Schneider, Zoe Arvanitakis, Sue E. Leurgans, David A. Bennett - Annals of Neurology 2009 cited by 931

  8. Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study

    Authors: David A. Bennett, Julie A. Schneider, Neelum T. Aggarwal, Zoe Arvanitakis, Raj C. Shah, Jeremiah F. Kelly, Jacob H. Fox, Elizabeth J. Cochran, Danielle Arends, Anna Treinkman, R. J. Wilson - Neuroepidemiology 2006 cited by 426

  9. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study

    Authors: Zoe Arvanitakis, Ana W. Capuano, Sue E. Leurgans, David A. Bennett, Julie A. Schneider - The Lancet Neurology 2016 cited by 591

  10. Overview and Findings from the Religious Orders Study

    Authors: David A. Bennett, Julie A. Schneider, Zoe Arvanitakis, R. J. Wilson - Current Alzheimer Research 2012 cited by 707

  11. Sex differences in Alzheimer’s disease and common neuropathologies of aging

    Authors: Shahram Oveisgharan, Zoe Arvanitakis, Lei Yu, José M. Farfel, Julie A. Schneider, David A. Bennett - Acta Neuropathologica 2018 cited by 342

  12. Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function

    Authors: Zoe Arvanitakis, R. J. Wilson, Julia L. Bienias, Denis A. Evans, David A. Bennett - Archives of Neurology 2004 cited by 1,262

  13. Mixed pathology is more likely in black than white decedents with Alzheimer dementia

    Authors: Lisa L. Barnes, Sue E. Leurgans, Neelum T. Aggarwal, Raj C. Shah, Zoe Arvanitakis, Bryan D. James, Aron S. Buchman, David A. Bennett, Julie A. Schneider - Neurology 2015 cited by 234

  14. Cerebral amyloid angiopathy pathology and cognitive domains in older persons

    Authors: Zoe Arvanitakis, Sue E. Leurgans, Zhenxin Wang, R. J. Wilson, David A. Bennett, Julie A. Schneider - Annals of Neurology 2010 cited by 379

  15. Microinfarct Pathology, Dementia, and Cognitive Systems

    Authors: Zoe Arvanitakis, Sue E. Leurgans, Lisa L. Barnes, David A. Bennett, Julie A. Schneider - Stroke 2011 cited by 406

  16. State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease

    Authors: Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, Ana W. Capuano, Han Tong, Vladislav Petyuk, Shannon L. Macauley, Xavier Fioramonti, Owen Carmichael, Frédéric Calon, Zoe Arvanitakis - Aging and Disease 2023 cited by 62

  17. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies

    Authors: Julie A. Schneider, Zoe Arvanitakis, Lei Yu, P. A. Boyle, Sue E. Leurgans, David A. Bennett - Brain 2012 cited by 288

  18. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function

    Authors: Zoe Arvanitakis, Hoau‐Yan Wang, Ana W. Capuano, Amber Khan, Bouchra Taïb, Frederick Anokye‐Danso, Julie A. Schneider, David A. Bennett, Rexford S. Ahima, Steven E. Arnold - Annals of Neurology 2020 cited by 98

  19. Insulin resistance, cognition, and Alzheimer disease

    Authors: Anne B. Kim, Zoe Arvanitakis - Obesity 2023 cited by 58

  20. The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts

    Authors: Zoe Arvanitakis, Ana W. Capuano, Sue E. Leurgans, Aron S. Buchman, David A. Bennett, Julie A. Schneider - Brain Pathology 2016 cited by 197

  21. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology

    Authors: Erin L. Abner, Peter T. Nelson, Richard J. Kryscio, Frederick A. Schmitt, David W. Fardo, Randall L. Woltjer, Nigel J. Cairns, Lei Yu, Hiroko H. Dodge, Chengjie Xiong, Kamal Masaki, Suzanne L. Tyas, David A. Bennett, Julie A. Schneider, Zoe Arvanitakis - Alzheimer s & Dementia 2016 cited by 230

  22. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4

    Authors: Shaowei Wang, Boyang Li, Victoria Solomon, Alfred N. Fonteh, Stanley I. Rapoport, David A. Bennett, Zoe Arvanitakis, Helena C. Chui, Patrick M. Sullivan, Hussein N. Yassine - Molecular Neurodegeneration 2022 cited by 64

  23. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer’s dementia

    Authors: Brandon Ebright, Isaac Assante, R Poblete, Shaowei Wang, Marlon Vincent V. Duro, David A. Bennett, Zoe Arvanitakis, Stan G. Louie, Hussein N. Yassine - Alzheimer s Research & Therapy 2022 cited by 55

  24. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies

    Authors: Mark Yarchoan, Jon B. Toledo, Edward B. Lee, Zoe Arvanitakis, Hala Kazi, Li-Ying Han, Natalia Louneva, Virginia M.‐Y. Lee, Sangwon F. Kim, John Q. Trojanowski, Steven E. Arnold - Acta Neuropathologica 2014 cited by 204